Fluoxetine and imipramine, which possess Sigma1R agonist properties, exhibited neuroprotective effects when PD was simulated by MPTP administration to mice or exposure of SH-SY5Y cells to MPP+. Here, SIGMAR1 is linked to Parkinson disease.